Previous studies highlighted that transcellular metabolism, by CD39 and CD73, of ATP and ADP released by activated platelets can mitigate the amplification of the thrombotic nidus formation, resulting in the reduction of ischemic stroke damage [24]. The gene discussed is ENTPD1; the disease is ischemic stroke.